Human induced pluripotent stem cell-derived kidney organoids toward clinical implementations

Publication date

2022-09-05T08:07:02Z

2022-09-05T08:07:02Z

2021-12-01

2022-08-22T18:25:16Z

Abstract

The generation of kidney organoids from human pluripotent stem cells (hPSCs) has represented a relevant scientific achievement in the organoid field. Importantly, hPSC-derived kidney organoids contain multiple nephron-like structures that exhibit some renal functional characteristics and have the capacity to respond to nephrotoxic agents. In this review, we first discuss how bioengineering approaches can help overcome current kidney organoid challenges. Next, we focus on recent works exploiting kidney organoids for drug screening and disease modeling applications. Finally, we provide a state of the art on current research toward the potential application of kidney organoids and renal cells derived from hPSCs for future renal replacement therapies.

Document Type

Article


Published version

Language

English

Related items

Reproducció del document publicat a: https://doi.org/10.1016/j.cobme.2021.100346

Current Opinion in Biomedical Engineering, 2021, vol. 20, num. 100346

https://doi.org/10.1016/j.cobme.2021.100346

Recommended citation

This citation was generated automatically.

Rights

cc by-nc-nd (c) Garreta, Elena et al., 2021

http://creativecommons.org/licenses/by-nc-nd/3.0/es/

This item appears in the following Collection(s)